Salih, Leonora J.
HRN: 09-79-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2024
MUPIROCIN 2%, 15G (TUBE)
08/17/2024
08/23/2024
TOPICAL
2%
BID
Pressure Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes